2 Unprofitable Stocks on Our Buy List and 1 We Brush Off [Yahoo! Finance]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Yahoo! Finance
Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising. Finding the right unprofitable companies is difficult, which is why we started StockStory - to help you navigate the market. Keeping that in mind, here are two unprofitable companies with the potential to become industry leaders and one best left off your radar. One Stock to Sell: Myriad Genetics (MYGN) Trailing 12-Month GAAP Operating Margin: -47% Founded in 1991 as one of the pioneers in translating genetic discoveries into clinical applications, Myriad Genetics (NASDAQ:MYGN) develops genetic tests that assess disease risk, guide treatment decisions, and provide insights across oncology, women's health, and mental health. Why Are We Out on MYGN? 4.6% annual revenue growth over the last two years was slower than its healthcare peers Negative returns on capital show management lost money while trying to expand the business, and its decreasing returns
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Myriad Genetics (MYGN) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Myriad Commercially Launches Precise MRD with Select Community Oncologists [Yahoo! Finance]Yahoo! Finance
- Myriad Commercially Launches Precise MRD with Select Community OncologistsGlobeNewswire
- Myriad Genetics (MYGN) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Why Myriad Genetics (MYGN) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
MYGN
Earnings
- 2/23/26 - Beat
MYGN
Sec Filings
- 3/5/26 - Form EFFECT
- 3/4/26 - Form 424B3
- 3/2/26 - Form 4
- MYGN's page on the SEC website